‘Gold standard’ for dementia care focuses on person-centered practices: panel … Delta, now a ‘variant of concern,’ accounts for 10% of new U.S. COVID cases, CDC says … Vaccine effort turns...
CDC issues clinical guidance for treating post-COVID conditions
By
Alicia Lasek
Jun 17, 2021
Many cases can be managed by primary care providers, federal health officials say. A lack of lab or imaging abnormalities does not invalidate the existence or severity of a patient’s symptoms or conditions,...
Nursing home COVID deaths level off, likely due to visits, unvaccinated staff, AARP reports
By
Alicia Lasek
Jun 14, 2021
The virus remains a threat, with more than 10,000 residents and staff members contracting the disease and 800 dying from it each month in federally certified facilities, according to a new analysis of...
Clinical briefs for Thursday, June 10
By
Alicia Lasek
Jun 10, 2021
Operator changes plans, will wait for full FDA approval to enforce COVID vaccination deadline among staff … Colorado drops mask mandate for assisted living communities … FDA panel member resigns over...
Safety means ‘seeing the virus’: Atria recounts rollout of 18,000 tests early in pandemic
By
Alicia Lasek
Jun 09, 2021
Finding a way to conduct COVID-19 testing among 31,000 residents and staff members across multiple states helped the senior living giant to “seal out” outbreaks and show that its communities were safe...
Engaging CNAs in COVID vaccination: 4 points to consider
By
Alicia Lasek
Jun 09, 2021
“Providing CNAs with information, resources, support, and opportunity will not only serve to improve vaccine receptivity, but may also have downstream benefits,” say geriatric nursing experts from...
FDA approves first drug to slow Alzheimer’s in controversial decision
By
Alicia Lasek
Jun 07, 2021
The evidence convincingly shows that aducanumab (Aduhelm) removes beta amyloid — a hallmark of Alzheimer’s — from the brain, slowing the disease’s progression and giving patients and families much-needed...
Two new drugs show promise for hard-to-treat breast, prostate cancers
By
Alicia Lasek
Jun 07, 2021
Cancer drug Lynparza (olaparib) reduced the risk of disease recurrence or death in certain aggressive breast cancers by 42% after surgery, while a new prostate cancer treatment improved survival by tracking...
Use the ‘5 C’s’ to tackle COVID vaccine hesitancy, physicians say
By
Alicia Lasek
Jun 04, 2021
The reasons for vaccine hesitancy — a delay in acceptance or refusal to be vaccinated — can be boiled down to five important factors that may help clinicians understand and better approach this issue,...
These 3 factors raise nursing assistants’ risk of shoulder injury in LTC
By
Alicia Lasek
Jun 03, 2021
Nursing assistants with a lower body mass index, a higher-level position, and a work-through-pain workstyle have greater odds of experiencing work-related shoulder injuries, according to a new study from...